Generalized anxiety disorder. Anxiety disorder due to known physiological condition
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosis of Generalized Anxiety Disorder (GAD) based on DSM-5 criteria by a psychiatrist at the counseling center 2. Absence of comorbid psychiatric disorders according to the psychiatrist’s assessment 3. Age between 18 and 55 years 4. Minimum education level of high school diploma 5. Active cooperation and participation throughout the treatment sessions 6. No prior experience of similar psychological treatment in the past six months 7. Willingness to participate and signing the written informed consent form
Exclusion criteria
Exclusion criteria: 1. Continuous use of medications that may interfere with the therapeutic interventions in the study 2. Presence of comorbid psychiatric disorders that hinder effective participation in therapy 3. Lack of cooperation or missing two consecutive therapy sessions 4. Refusal to sign the informed consent form or withdrawal from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Early maladaptive schemas score after treatment. Timepoint: Before the start of treatment (pre-test), at the end of the intervention period (post-test), at the 3-month follow-up after the end of treatment. Method of measurement: Using the Young Schema Questionnaire – Short Form (YSQ-SF), which includes 75 items rated on a 6-point Likert scale from 1 (completely untrue) to 6 (completely true). Higher scores indicate greater schema dysfunction. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cognitive flexibility score after treatment. Timepoint: Before the start of treatment (pre-test), at the end of the intervention period (post-test), at the 3-month follow-up after the end of treatment. Method of measurement: Using the Cognitive Flexibility Inventory (CFI) by Dennis & Vander Wal, consisting of 20 items on a 7-point Likert scale. Higher scores indicate greater cognitive flexibility.;Rumination score after treatment. Timepoint: Before the start of treatment (pre-test), at the end of the intervention period (post-test), at the 3-month follow-up after the end of treatment. Method of measurement: Using the Ruminative Responses Scale (RRS) by Nolen-Hoeksema & Morrow, consisting of 22 items on a 4-point scale from 1 (almost never) to 4 (almost always). Higher scores reflect more rumination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University